{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:38:09Z","timestamp":1790793489043,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":2150,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["RO1NS096748"],"award-info":[{"award-number":["RO1NS096748"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000910","name":"Conrad N. Hilton Foundation","doi-asserted-by":"publisher","award":["20150232"],"award-info":[{"award-number":["20150232"]}],"id":[{"id":"10.13039\/100000910","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001017","name":"California Community Foundation","doi-asserted-by":"publisher","award":["BAPP-15-118094"],"award-info":[{"award-number":["BAPP-15-118094"]}],"id":[{"id":"10.13039\/100001017","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tom Sherak MS Hope Foundation"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s13311-017-0562-7","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T11:18:10Z","timestamp":1501586290000},"page":"974-984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Pregnancy: Effect on Multiple Sclerosis, Treatment Considerations, and Breastfeeding"],"prefix":"10.1016","volume":"14","author":[{"given":"Rhonda","family":"Voskuhl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Callene","family":"Momtazee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1007\/s13311-017-0562-7_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrneurol.2012.43","article-title":"Sex-related factors in multiple sclerosis susceptibility and progression","volume":"8","author":"Voskuhl","year":"2012","journal-title":"Nat Rev Neurol"},{"issue":"5406","key":"10.1007\/s13311-017-0562-7_bib2","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1126\/science.283.5406.1277","article-title":"A gender gap in autoimmunity","volume":"283","author":"Whitacre","year":"1999","journal-title":"Science"},{"issue":"6","key":"10.1007\/s13311-017-0562-7_bib3","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00281-016-0584-y","article-title":"Pregnancy and multiple sclerosis: from molecular mechanisms to clinical application","volume":"38","author":"Gold","year":"2016","journal-title":"Semin Immunopathol"},{"issue":"10","key":"10.1007\/s13311-017-0562-7_bib4","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbagen.2009.10.002","article-title":"Actions of estrogens on glial cells: implications for neuroprotection","volume":"1800","author":"Arevalo","year":"2010","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1007\/s13311-017-0562-7_bib5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.steroids.2007.02.003","article-title":"Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implications","volume":"72","author":"Brann","year":"2007","journal-title":"Steroids"},{"issue":"5","key":"10.1007\/s13311-017-0562-7_bib6","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1073\/pnas.0438041100","article-title":"Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression","volume":"100","author":"Nilsen","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1007\/s13311-017-0562-7_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yfrne.2011.12.001","article-title":"Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration","volume":"33","author":"Spence","year":"2012","journal-title":"Front Neuroendocrinol"},{"issue":"11","key":"10.1007\/s13311-017-0562-7_bib8","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/jne.12108","article-title":"Rapid effects of oestrogen on synaptic plasticity: interactions with actin and its signalling proteins","volume":"25","author":"Babayan","year":"2013","journal-title":"J Neuroendocrinol"},{"issue":"3","key":"10.1007\/s13311-017-0562-7_bib9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nn2057","article-title":"Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory","volume":"11","author":"Liu","year":"2008","journal-title":"Nat Neurosci"},{"issue":"5","key":"10.1007\/s13311-017-0562-7_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1056\/NEJM199807303390501","article-title":"Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group","volume":"339","author":"Confavreux","year":"1998","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1007\/s13311-017-0562-7_bib11","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1177\/1352458514534105","article-title":"Multiparity in women with multiple sclerosis causes less long-term disability: yes","volume":"20","author":"D'Hooghe","year":"2014","journal-title":"Mult Scler"},{"issue":"11","key":"10.1007\/s13311-017-0562-7_bib12","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1177\/1352458514547731","article-title":"Multiparity in women with multiple sclerosis causes less long-term disability: commentary","volume":"20","author":"Hutchinson","year":"2014","journal-title":"Mult Scler"},{"issue":"11","key":"10.1007\/s13311-017-0562-7_bib13","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1177\/1352458514541979","article-title":"Multiparity in women with multiple sclerosis causes less long-term disability: no","volume":"20","author":"McCombe","year":"2014","journal-title":"Mult Scler"},{"issue":"5","key":"10.1007\/s13311-017-0562-7_bib14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00415-011-6267-7","article-title":"Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis","volume":"259","author":"D'Hooghe","year":"2012","journal-title":"J Neurol"},{"issue":"10","key":"10.1007\/s13311-017-0562-7_bib15","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1177\/1352458514561907","article-title":"Parity is associated with a longer time to reach irreversible disability milestones in women with multiple sclerosis","volume":"21","author":"Masera","year":"2015","journal-title":"Mult Scler"},{"issue":"Pt 1","key":"10.1007\/s13311-017-0562-7_bib16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/brain\/118.1.253","article-title":"Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis","volume":"118","author":"Runmarker","year":"1995","journal-title":"Brain"},{"issue":"1","key":"10.1007\/s13311-017-0562-7_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ana.24682","article-title":"Predictors of long-term disability accrual in relapse-onset multiple sclerosis","volume":"80","author":"Jokubaitis","year":"2016","journal-title":"Ann Neurol"},{"issue":"12","key":"10.1007\/s13311-017-0562-7_bib18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1212\/WNL.0b013e31824c4648","article-title":"Offspring number, pregnancy, and risk of a first clinical demyelinating event: the AusImmune Study","volume":"78","author":"Ponsonby","year":"2012","journal-title":"Neurology"},{"issue":"11","key":"10.1007\/s13311-017-0562-7_bib19","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S1474-4422(06)70581-6","article-title":"Sex ratio of multiple sclerosis in Canada: a longitudinal study","volume":"5","author":"Orton","year":"2006","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1007\/s13311-017-0562-7_bib20","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1212\/WNL.0b013e31824d1858","article-title":"Pregnancy: a \u201cmodifiable\u201d risk factor in MS?","volume":"78","author":"Daumer","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"10.1007\/s13311-017-0562-7_bib21","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.4049\/jimmunol.166.3.2080","article-title":"Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains","volume":"166","author":"Bebo","year":"2001","journal-title":"J Immunol"},{"issue":"2","key":"10.1007\/s13311-017-0562-7_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0165-5728(94)90030-2","article-title":"Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice","volume":"53","author":"Jansson","year":"1994","journal-title":"J Neuroimmunol"},{"issue":"6","key":"10.1007\/s13311-017-0562-7_bib23","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1212\/WNL.52.6.1230","article-title":"Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis","volume":"52","author":"Kim","year":"1999","journal-title":"Neurology"},{"issue":"1-2","key":"10.1007\/s13311-017-0562-7_bib24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jneuroim.2003.12.015","article-title":"Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis","volume":"149","author":"Palaszynski","year":"2004","journal-title":"J Neuroimmunol"},{"issue":"6","key":"10.1007\/s13311-017-0562-7_bib25","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.4049\/jimmunol.1001322","article-title":"Estriol generates tolerogenic dendritic cells in vivo that protect against autoimmunity","volume":"186","author":"Papenfuss","year":"2011","journal-title":"J Immunol"},{"issue":"8","key":"10.1007\/s13311-017-0562-7_bib26","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/labinvest.2012.76","article-title":"Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease","volume":"92","author":"Ziehn","year":"2012","journal-title":"Lab Invest"},{"issue":"2","key":"10.1007\/s13311-017-0562-7_bib27","first-page":"101","article-title":"Estriol: safety and efficacy","volume":"3","author":"Head","year":"1998","journal-title":"Altern Med Rev"},{"issue":"11","key":"10.1007\/s13311-017-0562-7_bib28","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1055\/s-2007-1011886","article-title":"Results of a 5 years prospective study of estriol succinate treatment in patients with climacteric complaints","volume":"19","author":"Lauritzen","year":"1987","journal-title":"Hormone Metab Res"},{"issue":"2","key":"10.1007\/s13311-017-0562-7_bib29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0378-5122(02)00037-3","article-title":"The effects of oral estriol on the endometrium in postmenopausal women","volume":"42","author":"Granberg","year":"2002","journal-title":"Maturitas"},{"issue":"4","key":"10.1007\/s13311-017-0562-7_bib30","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/00003081-200112000-00024","article-title":"Unconventional estrogens: estriol, biest, and triest","volume":"44","author":"Taylor","year":"2001","journal-title":"Clin Obstet Gynecol"},{"issue":"4","key":"10.1007\/s13311-017-0562-7_bib31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ana.10301","article-title":"Treatment of multiple sclerosis with the pregnancy hormone estriol","volume":"52","author":"Sicotte","year":"2002","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1007\/s13311-017-0562-7_bib32","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/labinvest.2009.79","article-title":"Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha)","volume":"89","author":"Gold","year":"2009","journal-title":"Lab Invest"},{"issue":"11","key":"10.1007\/s13311-017-0562-7_bib33","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.4049\/jimmunol.171.11.6267","article-title":"Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol","volume":"171","author":"Soldan","year":"2003","journal-title":"J Immunol"},{"issue":"1","key":"10.1007\/s13311-017-0562-7_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1474-4422(15)00322-1","article-title":"Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial","volume":"15","author":"Voskuhl","year":"2016","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1007\/s13311-017-0562-7_bib35","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1474-4422(16)00129-0","article-title":"Why use sex hormones in relapsing-remitting multiple sclerosis? Authors' reply","volume":"15","author":"Voskuhl","year":"2016","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1007\/s13311-017-0562-7_bib36","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000120","article-title":"Oral contraceptives combined with interferon beta in multiple sclerosis","volume":"2","author":"Pozzilli","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"10.1007\/s13311-017-0562-7_bib37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40263-016-0401-0","article-title":"Effect on cognition of estroprogestins combined with interferon beta in multiple sclerosis: analysis of secondary outcomes from a randomised controlled trial","volume":"31","author":"De Giglio","year":"2017","journal-title":"CNS Drugs"},{"issue":"1-2","key":"10.1007\/s13311-017-0562-7_bib38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jns.2009.08.056","article-title":"The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement","volume":"286","author":"Vukusic","year":"2009","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1007\/s13311-017-0562-7_bib39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/glia.1117","article-title":"Progesterone and the oligodendroglial lineage: stage-dependent biosynthesis and metabolism","volume":"36","author":"Gago","year":"2001","journal-title":"Glia"},{"issue":"1","key":"10.1007\/s13311-017-0562-7_bib40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pharmthera.2007.06.001","article-title":"Progesterone: therapeutic opportunities for neuroprotection and myelin repair","volume":"116","author":"Schumacher","year":"2007","journal-title":"Pharmacol Ther"},{"issue":"6","key":"10.1007\/s13311-017-0562-7_bib41","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1365-2826.2012.02284.x","article-title":"Neuroprotective effects of progesterone in chronic experimental autoimmune encephalomyelitis","volume":"24","author":"Giatti","year":"2012","journal-title":"J Neuroendocrinol"},{"issue":"2","key":"10.1007\/s13311-017-0562-7_bib42","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/exnr.2001.7783","article-title":"Divergent effects of ovarian steroids on neuronal survival during experimental allergic encephalitis in Lewis rats","volume":"171","author":"Hoffman","year":"2001","journal-title":"Exp Neurol"},{"issue":"2","key":"10.1007\/s13311-017-0562-7_bib43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0165-0378(89)90033-8","article-title":"Oestrogen induced suppression of collagen arthritis. IV: Progesterone alone does not affect the course of arthritis but enhances the oestrogen-mediated therapeutic effect","volume":"15","author":"Jansson","year":"1989","journal-title":"J Reprod Immunol"},{"issue":"4","key":"10.1007\/s13311-017-0562-7_bib44","first-page":"A372","article-title":"Female sex hormones at supraphysiologic, but not physiologic, levels decrease EAE severity in female SJL mice","volume":"15","author":"Voskuhl","year":"2001","journal-title":"FASEB J"},{"issue":"8","key":"10.1007\/s13311-017-0562-7_bib45","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.4049\/jimmunol.1000588","article-title":"Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects","volume":"185","author":"Correale","year":"2010","journal-title":"J Immunol"},{"key":"10.1007\/s13311-017-0562-7_bib46","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/nyas.12432","article-title":"Vitamin D, steroid hormones, and autoimmunity","volume":"1317","author":"Cutolo","year":"2014","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1007\/s13311-017-0562-7_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2010.09.047","article-title":"Estrogen-vitamin D interaction in multiple sclerosis","volume":"95","author":"Disanto","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1007\/s13311-017-0562-7_bib48","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.autrev.2016.07.002","article-title":"Network of nuclear receptor ligands in multiple sclerosis: common pathways and interactions of sex-steroids, corticosteroids and vitamin D3-derived molecules","volume":"15","author":"Rolf","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1007\/s13311-017-0562-7_bib49","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jneuroim.2015.06.015","article-title":"Vitamin D and estrogen synergy in Vdr-expressing CD4(+) T cells is essential to induce Helios(+)FoxP3(+) T cells and prevent autoimmune demyelinating disease","volume":"286","author":"Spanier","year":"2015","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1007\/s13311-017-0562-7_bib50","doi-asserted-by":"crossref","first-page":"E181","DOI":"10.1073\/pnas.1617115114","article-title":"Glucocorticoid receptor in T cells mediates protection from autoimmunity in pregnancy","volume":"114","author":"Engler","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1007\/s13311-017-0562-7_bib51","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/ana.23745","article-title":"Increase in multiple sclerosis activity after assisted reproduction technology","volume":"72","author":"Correale","year":"2012","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1007\/s13311-017-0562-7_bib52","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.contraception.2011.07.013","article-title":"Unintended pregnancy in the United States: incidence and disparities, 2006","volume":"84","author":"Finer","year":"2011","journal-title":"Contraception"},{"issue":"9","key":"10.1007\/s13311-017-0562-7_bib53","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1001\/archneur.62.9.1362","article-title":"Recent use of oral contraceptives and the risk of multiple sclerosis","volume":"62","author":"Alonso","year":"2005","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1007\/s13311-017-0562-7_bib54","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1212\/WNL.55.6.848","article-title":"Oral contraceptives and the incidence of multiple sclerosis","volume":"55","author":"Hernan","year":"2000","journal-title":"Neurology"},{"issue":"12","key":"10.1007\/s13311-017-0562-7_bib55","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/j.1471-0528.1998.tb10008.x","article-title":"The influence of oral contraceptives on the risk of multiple sclerosis","volume":"105","author":"Thorogood","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"5","key":"10.1007\/s13311-017-0562-7_bib56","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1007\/s00415-012-6653-9","article-title":"Multiple sclerosis and pregnancy: therapeutic considerations","volume":"260","author":"Houtchens","year":"2013","journal-title":"J Neurol"},{"issue":"6","key":"10.1007\/s13311-017-0562-7_bib57","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/1352458516634872","article-title":"Interferon-beta exposure during first trimester is safe in women with multiple sclerosis\u2014a prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry","volume":"22","author":"Thiel","year":"2016","journal-title":"Mult Scler"},{"issue":"5","key":"10.1007\/s13311-017-0562-7_bib58","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004536","article-title":"Final results from the Betaseron (interferon beta-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events","volume":"4","author":"Coyle","year":"2014","journal-title":"BMJ Open"},{"issue":"8","key":"10.1007\/s13311-017-0562-7_bib59","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.0000000000000137","article-title":"Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis","volume":"82","author":"Karlsson","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1007\/s13311-017-0562-7_bib60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40120-015-0033-1","article-title":"Delayed-release dimethyl fumarate and pregnancy: preclinical studies and pregnancy outcomes from clinical trials and postmarketing experience","volume":"4","author":"Gold","year":"2015","journal-title":"Neurol Ther"},{"issue":"2","key":"10.1007\/s13311-017-0562-7_bib61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40120-014-0020-y","article-title":"Pregnancy outcomes following maternal and paternal exposure to teriflunomide during treatment for relapsing-remitting multiple sclerosis","volume":"3","author":"Kieseier","year":"2014","journal-title":"Neurol Ther"},{"issue":"1","key":"10.1007\/s13311-017-0562-7_bib62","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12883-016-0674-4","article-title":"Evaluation of pregnancy outcomes from the Tysabri(R) (natalizumab) pregnancy exposure registry: a global, observational, follow-up study","volume":"16","author":"Friend","year":"2016","journal-title":"BMC Neurol"},{"issue":"7","key":"10.1007\/s13311-017-0562-7_bib63","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1177\/1352458512471880","article-title":"Update on reproductive safety of current and emerging disease-modifying therapies for multiple sclerosis","volume":"19","author":"Cree","year":"2013","journal-title":"Mult Scler"},{"issue":"Pt 6","key":"10.1007\/s13311-017-0562-7_bib64","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/brain\/awh152","article-title":"Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse","volume":"127","author":"Vukusic","year":"2004","journal-title":"Brain"},{"issue":"10","key":"10.1007\/s13311-017-0562-7_bib65","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jamaneurol.2015.1806","article-title":"Exclusive Breastfeeding and the Effect on Postpartum Multiple Sclerosis Relapses","volume":"72","author":"Hellwig","year":"2015","journal-title":"JAMA Neurol"},{"issue":"10","key":"10.1007\/s13311-017-0562-7_bib66","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1007\/s00415-012-6553-z","article-title":"Breastfeeding and multiple sclerosis relapses: a meta-analysis","volume":"259","author":"Pakpoor","year":"2012","journal-title":"J Neurol"},{"issue":"5","key":"10.1007\/s13311-017-0562-7_bib67","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/ana.410290514","article-title":"The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine","volume":"29","author":"Riskind","year":"1991","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1007\/s13311-017-0562-7_bib68","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1523\/JNEUROSCI.4441-06.2007","article-title":"White matter plasticity and enhanced remyelination in the maternal CNS","volume":"27","author":"Gregg","year":"2007","journal-title":"J Neurosci"},{"issue":"2","key":"10.1007\/s13311-017-0562-7_bib69","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/bfm.2011.0044","article-title":"Transfer of interferon beta-1a into human breastmilk","volume":"7","author":"Hale","year":"2012","journal-title":"Breastfeed Med"},{"issue":"2","key":"10.1007\/s13311-017-0562-7_bib70","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/0890334414566237","article-title":"Transfer of natalizumab into breast milk in a mother with multiple sclerosis","volume":"31","author":"Baker","year":"2015","journal-title":"J Hum Lact"},{"key":"10.1007\/s13311-017-0562-7_bib71","first-page":"6527458","article-title":"Management of multiple sclerosis in the breastfeeding mother","volume":"2016","author":"Almas","year":"2016","journal-title":"Mult Scler Int"},{"issue":"8","key":"10.1007\/s13311-017-0562-7_bib72","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/1933719108324138","article-title":"Multiple sclerosis and reproductive risks in women","volume":"15","author":"Argyriou","year":"2008","journal-title":"Reprod Sci"},{"issue":"2","key":"10.1007\/s13311-017-0562-7_bib73","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/0890334415570970","article-title":"Transfer of methylprednisolone into breast milk in a mother with multiple sclerosis","volume":"31","author":"Cooper","year":"2015","journal-title":"J Hum Lact"},{"issue":"9","key":"10.1007\/s13311-017-0562-7_bib74","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/jama.2016.12126","article-title":"Association between MRI exposure during pregnancy and fetal and childhood outcomes","volume":"316","author":"Ray","year":"2016","journal-title":"JAMA"},{"issue":"4","key":"10.1007\/s13311-017-0562-7_bib75","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/jmri.22413","article-title":"Is administration of gadolinium-based contrast media to pregnant women and small children justified?","volume":"34","author":"Sundgren","year":"2011","journal-title":"J Magn Reson Imaging"},{"issue":"6","key":"10.1007\/s13311-017-0562-7_bib76","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1148\/rg.2015150031","article-title":"Imaging pregnant and lactating patients","volume":"35","author":"Tirada","year":"2015","journal-title":"Radiographics"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-017-0562-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-017-0562-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923014186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923014186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-017-0562-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:59:27Z","timestamp":1761807567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923014186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1878747923014186"],"URL":"https:\/\/doi.org\/10.1007\/s13311-017-0562-7","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy: Effect on Multiple Sclerosis, Treatment Considerations, and Breastfeeding","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-017-0562-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}